Gut microbiota and colorectal tumor
Not Applicable
Suspended
- Conditions
- colorectal cancer FAP
- Registration Number
- JPRN-UMIN000039081
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients for whom consent was not obtained. 2. Patients with serious infections.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method gut microbiota analysis
- Secondary Outcome Measures
Name Time Method mouse experiments with isolated bacterium from patients
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link gut microbiota to colorectal cancer progression in FAP patients?
Are there specific gut microbial biomarkers that predict response to FAP-targeted therapies in colorectal cancer?
How does gut microbiota modulation compare to standard-of-care treatments for FAP-related colorectal tumors?
What adverse events are associated with gut microbiota interventions in colorectal cancer clinical trials?
What combination therapies with gut microbiota modulation are being explored for FAP and colorectal cancer?